Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
R., Ratamess, N
Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis
To understand the underlying mechanisms, inhibitors targeting the Notch pathway (DAPT) and NF-B pathway (BMS) were also applied to HUVEC and murine CLI models
That alone has been worth it for me
Certain injectable formulations discussed on this page are FDA-approved for specific indications (e.g., cyanocobalamin for vitamin B12 deficiency)
US$ 28.32
US$ 21.83
US$ 22.27
US$ 26.99
US$ 26.81
US$ 26.67
